Applies to canakinumab: subcutaneous powder for solution
In addition to its needed effects, some unwanted effects may be caused by canakinumab. In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking canakinumab, check with your doctor or nurse immediately:
Some of the side effects that can occur with canakinumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to canakinumab: subcutaneous powder for injection
Very common (10% or more): Diarrhea (20%), nausea (14%), gastroenteritis, tonsillitis, upper abdominal pain, gastroesophageal reflux disease[Ref]
Very common (10% or more): Urinary tract infection[Ref]
Very common (10% or more): LeukopeniaFrequency not reported: Hemoglobin increased, decreased white blood cells, decreased neutrophils, decreased platelets[Ref]
Rare (less than 0.1%): Elevated transaminasesFrequency not reported: Elevated serum bilirubin[Ref]
Frequency not reported: Hypersensitivity reactions (unspecified)[Ref]
Very common (10% or more): Influenza (17%), viral infection (13%)[Ref]
Very common (10% or more): Injection site reaction[Ref]
Very common (10% or more): Musculoskeletal pain (11%), arthralgiaCommon (1% to 10%): Back pain[Ref]
Very common (10% or more): Headache (14%), dizziness/vertigo (11%)[Ref]
Very common (10% or more): Ear infectionCommon (1% to 10%): Fatigue/asthenia[Ref]
Very common (10% or more): Nasopharyngitis (34%), rhinitis (17%), bronchitis (11%), pneumonia, sinusitis, rhinitis, pharyngitis, upper respiratory tract infection[Ref]
Very common (10% or more): Cellulitis[Ref]
Very common (10% or more): Weight gain (11%)[Ref]
Very common (10% or more): Creatinine clearance decreased, proteinuria[Ref]
1. "Product Information. Ilaris (canakinumab)." Novartis Pharmaceuticals, East Hanover, NJ. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
3. Cerner Multum,  Inc. "Australian Product Information." O 0
Not all side effects for canakinumab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Body aches or pain
chills
congestion
cough
diarrhea
dryness or soreness of the throat
fever
headache
hoarseness
joint pain
loss of appetite
muscle aches and pains
nausea
shivering
shortness of breath
sneezing
stuffy or runny nose
sweating
tender, swollen glands in the neck
tightness in the chest
trouble sleeping
trouble swallowing
unusual tiredness or weakness
voice changes
vomiting


Abdominal or stomach pain
bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
dizziness or lightheadedness
feeling of constant movement of self or surroundings
increased weight
muscle or bone pain
sensation of spinning
weakness

